Vivesto AB (OTCPK:OASMY)
$ 0.0499 0 (0%) Market Cap: 8.95 Mil Enterprise Value: 3.84 Mil PE Ratio: 0 PB Ratio: 0.87 GF Score: 33/100

Q3 2021 Oasmia Pharmaceutical AB Earnings Call Transcript

Nov 18, 2021 / 09:00AM GMT
Release Date Price: $0.7135
Operator

Please go ahead.

Francois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB

()-

Thank you very much, and good morning, everyone. I'm very pleased to be here today, although I've got a strong cold. So I do apologize for some of the tones of my voice, but very pleased to be with you to update you on our progress of the last quarter. So Slide 2 please, which is a forward-looking statement. Slide 3 shows Fredrik, that's together with me, we'll go through this Q3 report presentation.

Let's go to Slide 4. So I thought it will be important to recap very quickly what has been done over the last 18 months. Since March 2020, when I joined Oasmia, I've been focusing all my efforts together with my colleagues to transform the business. We've been taking a number of important steps to get the company ready for the future. That means, first, streamlining our activities to focus on growth opportunities; two, strengthening our balance sheet and getting the best value from our standing; three, and this is very important, building our in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot